No Data
Beeplatts, QPS Research Institute and others.
LeTech has revised its Financial Estimates for Dividends, cancelling the year-end dividend. Sumitomo Forestry is set to carry out a public buyout at a price of 686 yen per share, and is expected to be (Delisted) after the buyout. GNEXT has revised its performance estimates, projecting an operating loss of 0.169 billion yen this period, down from a previous estimate of -1.40 to -0.1 billion yen. A mid-term management plan covering the fiscal years from March 2026 to March 2028 has been formulated, with an operating profit target of 0.80 to 0.09 billion yen for the fiscal year ending in March 2028. BePlatts is involved in financial services and the planning of corporate strategies.
Express News | 【Change Report】 Hitachi High-Tech reported a reduction in the shareholding of Precision System Science (7707.JP) to 0.0%.
Express News | [Change Report] Hitachi High-Tech reports a decrease in its shareholding in Precision System Science (7707.JP) to 6.76%.
Japanese stock buybacks this week (3/3~3/7)
――――3/3――――$Amiya(4258.JP)$ will buy back up to 100K shares, 2.42% of its outstanding shares (excluding its own shares), for an amount of JPY¥ 300 million.$Mizuho Financial Group(8411.JP)$ will
Softness and the decline in US stocks weigh down [Emerging Markets Individual Stock Global Strategy].
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to show a weak performance. In the U.S. stock market yesterday, October 6th, the Dow Inc fell by 427.51 points (-0.99%) to 42,579.08. Concerns over economic slowdown intensified due to the widening trade deficit, while selling related to heightened friction with other countries weighed on stock prices. Meanwhile, President Trump announced some reductions in tariffs on Mexico and Canada, but there was little recovery, and the market finished in the lower range. Today, selling will dominate the Emerging Markets.
PSS, Renascience and others.
From the 6th, the number of shares to be delivered for the large exercise of subscription rights for Mobcast HD's 35th round (with exercise price adjustment clauses) will be 2.1 million shares. Renascience <4889> achieved the primary endpoint in the validation clinical performance study of Artificial Intelligence (AI) predicting insulin dosage for diabetic patients. PSS <7707> will conduct a Share Buyback, with a maximum of 440,600 shares (1.59% of the outstanding shares) to be purchased on the 7th via ToSTNeT-3.
